Sisram Medical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 17 shareholders own 72.76% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
71.4%	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	334,504,800	HK$1.2b	0.78%	no data
0.46%	China Universal Asset Management Company Ltd.	2,158,400	HK$7.9m	0%	no data
0.3%	China Southern Asset Management Co., Ltd.	1,394,200	HK$5.1m	0%	no data
0.2%	Lior Dayan	938,500	HK$3.5m	0%	no data
0.093%	WisdomTree Asset Management, Inc.	436,800	HK$1.6m	-2.15%	no data
0.087%	Segall Bryant & Hamill, LLC	409,179	HK$1.5m	0%	no data
0.085%	State Street Global Advisors, Inc.	397,600	HK$1.5m	-2.74%	no data
0.053%	Yi Liu	250,000	HK$920.0k	0%	no data
0.022%	BNY Mellon Asset Management	100,800	HK$370.9k	11.5%	no data
0.017%	Guojun Bu	80,000	HK$294.4k	0%	no data
0.012%	Phoenix Investments & Finances Ltd	56,426	HK$207.7k	0%	no data
0.0048%	KLP Kapitalforvaltning AS	22,400	HK$82.4k	0%	no data
0.0014%	LGIM Managers (Europe) Limited	6,800	HK$25.0k	0%	no data
0.0012%	Pictet Asset Management Limited	5,699	HK$21.0k	0%	no data
0.0011%	GWL Investment Management Ltd.	5,332	HK$19.6k	0%	no data
0.00017%	Connor, Clark & Lunn Investment Management Ltd.	800	HK$2.9k	-66.7%	no data
0.00009%	LGT Capital Partners Ltd.	400	HK$1.6k	0%	no data